Emerging Trends in Tyrosine Kinase Inhibitors Market and Targeted Cancer Therapy
Tyrosine kinase inhibitors (TKIs) have revolutionized cancer treatment by providing targeted therapies that block specific cellular signaling pathways essential for tumor growth and survival. These small molecules selectively inhibit tyrosine kinases, enzymes that transfer phosphate groups from ATP to tyrosine residues, disrupting uncontrolled cellular proliferation. TKIs have significantly...
0 Commenti 0 condivisioni 511 Views 0 Anteprima
Sponsorizzato
Sponsorizzato
Sponsorizzato
Sponsorizzato